ADVENT at UEG Week 2026

• Explain how treat-to-target strategies from IBD may be applied to disease monitoring in EoE
• Understand the chronic, progressive nature of EoE, disease remodeling, and subclinical disease activity missed by symptom-based management
• Evaluate evidence on EoE natural history and apply treat-to-target strategies in clinical practice

Sit down with three leading experts—Professors David Rubin, MD; Evan Dellon, MD, MPH; and Thomas Greuter, MD—for a patient case–based roundtable discussion bringing together inflammatory bowel disease (IBD) and eosinophilic esophagitis (EoE) perspectives on progression and esophageal remodeling in EoE. 

During the discussion, the panelists aim to help the audience learn about the progressive nature of EoE, best practices for diagnosis and management, and evolving treatment options for patients based on the latest data—including key learnings from the IBD treat-to-target paradigm and how they may apply to EoE management.